Literature DB >> 22296808

RPE cell senescence: a key contributor to age-related macular degeneration.

Michael R Kozlowski1.   

Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness in industrialized countries. Although much progress has been made recently in the management of later stages of the disease, no agents have yet been developed for the early stages or for prophylactic use. Furthermore, even the treatments for the later stages have limited effectiveness. The process of developing improved treatments for AMD is complicated by the existence of several theories concerning the cause of the disorder, each suggesting a different strategy for finding effective therapeutics. One of the potential contributors to AMD pathology is retinal pigment epithelial (RPE) cell senescence. The present paper hypothesizes that RPE senescence plays a central role in the etiology of AMD. This hypothesis is supported by the ability of RPE cell senescence to account for the signs, risk factors, and successful treatment modalities of the disorder. This hypothesis also points to several new prophylactic and treatment strategies for AMD. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22296808     DOI: 10.1016/j.mehy.2012.01.018

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  45 in total

1.  Clinical strategies and animal models for developing senolytic agents.

Authors:  James L Kirkland; Tamara Tchkonia
Journal:  Exp Gerontol       Date:  2014-10-28       Impact factor: 4.032

2.  Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report.

Authors:  Paolo Giuseppe Limoli; Enzo Maria Vingolo; Celeste Limoli; Sergio Zaccaria Scalinci; Marcella Nebbioso
Journal:  J Vis Exp       Date:  2018-02-12       Impact factor: 1.355

3.  Effect of Methyl-CpG binding domain protein 2 (MBD2) on AMD-like lesions in ApoE-deficient mice.

Authors:  Jun-Ru Pan; Chen Wang; Qi-Lin Yu; Shu Zhang; Bin Li; Jun Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

Review 4.  Senescent cells: a novel therapeutic target for aging and age-related diseases.

Authors:  R M Naylor; D J Baker; J M van Deursen
Journal:  Clin Pharmacol Ther       Date:  2012-12-05       Impact factor: 6.875

5.  Klotho regulates retinal pigment epithelial functions and protects against oxidative stress.

Authors:  Maria Kokkinaki; Mones Abu-Asab; Nishantha Gunawardena; Gerard Ahern; Monica Javidnia; John Young; Nady Golestaneh
Journal:  J Neurosci       Date:  2013-10-09       Impact factor: 6.167

Review 6.  Retinal pigment epithelium development, plasticity, and tissue homeostasis.

Authors:  Sabine Fuhrmann; ChangJiang Zou; Edward M Levine
Journal:  Exp Eye Res       Date:  2013-09-21       Impact factor: 3.467

Review 7.  Mitochondrial quality control in AMD: does mitophagy play a pivotal role?

Authors:  Juha M T Hyttinen; Johanna Viiri; Kai Kaarniranta; Janusz Błasiak
Journal:  Cell Mol Life Sci       Date:  2018-05-18       Impact factor: 9.261

Review 8.  Senescence in the pathogenesis of age-related macular degeneration.

Authors:  Janusz Blasiak
Journal:  Cell Mol Life Sci       Date:  2020-01-02       Impact factor: 9.261

9.  Targeting senescent retinal pigment epithelial cells facilitates retinal regeneration in mouse models of age-related macular degeneration.

Authors:  Jae-Byoung Chae; Hyoik Jang; Chanok Son; Chul-Woo Park; Huyeon Choi; Seongeon Jin; Ho-Yeon Lee; Hyungwoo Lee; Ja-Hyoung Ryu; Namshin Kim; Chaekyu Kim; Hyewon Chung
Journal:  Geroscience       Date:  2021-10-02       Impact factor: 7.713

Review 10.  Potential of Telomerase in Age-Related Macular Degeneration-Involvement of Senescence, DNA Damage Response and Autophagy and a Key Role of PGC-1α.

Authors:  Janusz Blasiak; Joanna Szczepanska; Michal Fila; Elzbieta Pawlowska; Kai Kaarniranta
Journal:  Int J Mol Sci       Date:  2021-07-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.